Rodent In Vivo PK Service

Creative Biolabs provides accurate, quantifiable data on the fundamental behavior of your test compound within a living system. We deliver a complete pharmacokinetic profile, including parameters like exposure, distribution, and clearance, enabling confident decision-making for lead optimization. Clients gain rapid, high-quality data that directly informs compound selection, formulation strategies, and further biological evaluation. This service is designed to accelerate the research phase of your development pipeline.

Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us

Why Do Rodent In Vivo PK

Rodent in vivo pharmacokinetics (PK) refers to the study of how a drug behaves within the body of rodent species, such as mice or rats, over time after administration. A PK study is important in drug development to understand the absorption, distribution, metabolism, and excretion (ADME) of a drug in living organisms. This study provides valuable insights into the pharmacokinetic behavior of drugs in living organisms, helping to optimize dosing regimens, predict human pharmacokinetics, and assess drug safety and efficacy in preclinical settings.

To ascertain the full scope of our capabilities, prospective clients are invited to submit a consultation request.

Fig.1 Antimalarial drug discovery workflow. (OA Literature)Fig.1 Rodent model (in vivo) is part and parcel of the drug discovery. 1

What We Can Offer

Rodent in vivo pharmacokinetics has numerous applications across various stages of drug discovery, development, and preclinical research. Here are some key applications:

• Safety and Toxicity Assessment • Drug Candidate Selection • Pharmacokinetic Modeling and Simulation • Metabolite Identification and Characterization
• Drug-Drug Interactions • Dose Optimization • Species Selection and Translational Research • Bioavailability and Formulation Development

How Creative Biolabs' service Can Assist Your Projects

Creative Biolabs provides the expertise, facilities, and resources for preclinical pharmacokinetic studies in rodents for drug development and research purposes. The following is a detailed description of the content of PK services in rodents:

Core steps of rodent in vivo PK service. (Creative Biolabs Original)

In addition to the in vivo PK study process described above, Creative Biolabs interprets PK parameters based on your research objectives and pharmacological properties throughout the project, implements quality control measures throughout the study to ensure data reliability and reproducibility, and conducts the study in accordance with ethical guidelines and regulations governing the use of animals in the study.

Highlights

One-Stop DMPK Service

We provide integrated solutions from initial study design through to comprehensive bioanalysis and final data reporting. This seamless, end-to-end service simplifies your outsourcing needs and accelerates project delivery without requiring multiple vendor handoffs.

High Standards of Animal Welfare

Our commitment to ethical conduct is upheld in AAALAC-accredited facilities, ensuring rigorous adherence to established animal care protocols. We prioritize minimizing animal numbers through advanced, compound-sparing microsampling techniques.

Service Features

Professional Animal Research Team

Our dedicated team comprises experienced veterinary staff, certified technicians, and PhD-level pharmacokineticists. This expertise guarantees the flawless execution of complex dosing and sampling procedures, ensuring the highest integrity of your in vivo data.

Rich Project Experience

With extensive experience across various therapeutic areas and compound modalities (small molecules, peptides, biologics), Creative Biolabs confidently addresses unique research challenges, providing informed study design and reliable results every time.

Discover how a partnership with us can streamline your research - Get a quote today.

Customer Reviews

FAQs

What is the difference between the rodent in vivo PK and the small animal in vivo PK?

Rodent In Vivo PK: Often used in biomedical research and drug development, where rodents are commonly employed as model organisms due to their small size, ease of handling, and genetic tractability.
Small Animal In Vivo PK: This can be applied in various research contexts, including biomedical research, pharmacology, toxicology, and environmental science, depending on the specific small animal species used and the research objectives.

What are the species of rodent pharmacokinetics?

For rodent pharmacokinetic studies, particularly in preclinical research, the two most commonly used species are mice (Mus musculus) and rats (Rattus norvegicus). The choice between them often depends on factors such as the specific objectives of the study, the properties of the drug being tested, and practical considerations such as availability and cost. Additionally, other small rodent species like hamsters or gerbils may be used in specific research contexts, although they are less common compared to mice and rats.

Related Services

Non-rodent In Vivo PK Service

Provides pharmacokinetic evaluation in non-rodent species, such as canines or non-human primates, to enhance translational relevance and fulfill regulatory requirements.

Learn More →

Single Mouse Single PK Platform

An innovative platform enabling the acquisition of a complete PK profile from a single mouse, significantly reducing animal usage and compound requirements while improving data quality.

Learn More →

How to Contact Us

Creative Biolabs' rodent in vivo PK service is designed to deliver high-fidelity, actionable pharmacokinetic data, significantly derisking your compound evaluation program and accelerating the transition of promising candidates into advanced research stages. Please feel free to contact us to discuss your specific PK study requirements and receive a customized project proposal.

Reference

  1. Adebayo, Glory et al. "The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery." Pharmaceuticals (Basel, Switzerland) vol. 18,3 424. 18 Mar. 2025. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ph18030424
Loading case studies...
Online Inquiry